메뉴 건너뛰기
Digestive Diseases and Sciences
Volumn 41, Issue 3, 1996, Pages 624-626
Pleuropericarditis related to the use of mesalamine
Author keywords

Drug hypersensitivity; Inflammatory bowel disease; Mesalamine; Pericarditis
Indexed keywords

MESALAZINE;
EID: 0029913064     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02282352     Document Type: Article
Times cited : (45)
References (12)
  • 1
    • 0015374469 scopus 로고
    • Absorption, metabolism, and excretion of salicylazosulphapyridine in man
    • Schroder H, Campbell DES: Absorption, metabolism, and excretion of salicylazosulphapyridine in man. Clin Pharmacol Ther 13:539-551, 1972
    • (1972) Clin Pharmacol Ther , vol.13 , pp. 539-551
    • Schroder, H.1    Campbell, D.E.S.2
  • 2
    • 0017151106 scopus 로고
    • Clinical Pharmacokinetics of sulphasalazine
    • Das KM, Dubin R: Clinical Pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1:406-425, 1976
    • (1976) Clin Pharmacokinet , vol.1 , pp. 406-425
    • Das, K.M.1    Dubin, R.2
  • 3
    • 0024556869 scopus 로고
    • Cardiac hypersensitivity to 5-aminosalicylic acid
    • Agnholt J, Soerensen HT, Rasmussen SN, et al: Cardiac hypersensitivity to 5-aminosalicylic acid. Lancet 2:1135, 1989
    • (1989) Lancet , vol.2 , pp. 1135
    • Agnholt, J.1    Soerensen, H.T.2    Rasmussen, S.N.3
  • 4
    • 0020700213 scopus 로고
    • Pleuropericarditis: An extraintestinal complication of inflammatory bowel disease
    • Patwardhan RV, Heilpern J, Brewster AD, Darra JJ: Pleuropericarditis: An extraintestinal complication of inflammatory bowel disease. Arch Intern Med 143:94-96, 1983
    • (1983) Arch Intern Med , vol.143 , pp. 94-96
    • Patwardhan, R.V.1    Heilpern, J.2    Brewster, A.D.3    Darra, J.J.4
  • 5
    • 0019984043 scopus 로고
    • Sulfasuxidine-induced lupus syndrome in a patient with Crohn's disease
    • Barr-Locke D: Sulfasuxidine-induced lupus syndrome in a patient with Crohn's disease. Am J Gastroenterol 77:614-615, 1982
    • (1982) Am J Gastroenterol , vol.77 , pp. 614-615
    • Barr-Locke, D.1
  • 6
    • 0023971172 scopus 로고
    • Sulfasalazine-induced lupus erythematosis
    • Clementz GL, Dolin BJ: Sulfasalazine-induced lupus erythematosis. Am J Med 84:535-538, 1488
    • (1488) Am J Med , vol.84 , pp. 535-538
    • Clementz, G.L.1    Dolin, B.J.2
  • 7
    • 0024486089 scopus 로고
    • Sulfasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis
    • Deboever G, Devogelaere R, Holvoet G: Sulfasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis. Am J Gastroenterol 84:85-86, 1989
    • (1989) Am J Gastroenterol , vol.84 , pp. 85-86
    • Deboever, G.1    Devogelaere, R.2    Holvoet, G.3
  • 8
    • 0003189484 scopus 로고
    • FDA rare adverse reaction with Rowasa
    • FDA rare adverse reaction with Rowasa. FDA Drug Bull 19:17-18, 1989
    • (1989) FDA Drug Bull , vol.19 , pp. 17-18
  • 9
    • 0025350913 scopus 로고
    • Fatal myocarditis associated with mesalazine
    • Kristensen KS, Hoegholm A, Bohr L, et al: Fatal myocarditis associated with mesalazine. Lancet 335:605, 1990
    • (1990) Lancet , vol.335 , pp. 605
    • Kristensen, K.S.1    Hoegholm, A.2    Bohr, L.3
  • 10
    • 0025268138 scopus 로고
    • Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease
    • Jenss H, Becker EW, Weher P: Pericardial effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease. Am J Gastroenterol 85:332-333, 1990
    • (1990) Am J Gastroenterol , vol.85 , pp. 332-333
    • Jenss, H.1    Becker, E.W.2    Weher, P.3
  • 11
    • 0024255885 scopus 로고
    • Long-term treatment with olsalazine of ulcerative colitis: Safety and relapse prevention: A follow-up study
    • Sandberg-Gertzen H, Jarnerot G, Tysk C: Long-term treatment with olsalazine of ulcerative colitis: Safety and relapse prevention: A follow-up study. Scand J Gastroenterol 23:48-50, 1988
    • (1988) Scand J Gastroenterol , vol.23 , pp. 48-50
    • Sandberg-Gertzen, H.1    Jarnerot, G.2    Tysk, C.3
  • 12
    • 0028804562 scopus 로고
    • Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
    • Miner P, Hanauer S, Robinson M, et al: Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Dig Dis Sci 40:296-304, 1995
    • (1995) Dig Dis Sci , vol.40 , pp. 296-304
    • Miner, P.1    Hanauer, S.2    Robinson, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.